Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01798381
Other study ID # OCEAN-GER
Secondary ID
Status Completed
Phase Phase 3
First received
Last updated
Start date December 2012
Est. completion date December 2015

Study information

Verified date October 2020
Source Saarland University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The aim of this project is to investigate the effect of a dietary supplementation with essential fatty acids in adults on cognitive functions related to attention and impulse control in the general population and in individuals with a diagnosis of attention deficit hyperactivity disorder (ADHD).


Recruitment information / eligibility

Status Completed
Enrollment 100
Est. completion date December 2015
Est. primary completion date December 2014
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years to 60 Years
Eligibility Inclusion Criteria: - DSM-IV ADHD Exclusion Criteria: - any acute psychiatric disorder

Study Design


Related Conditions & MeSH terms

  • Adult Attention Deficit Hyperactivity Disorder
  • Attention Deficit Disorder with Hyperactivity
  • Hyperkinesis

Intervention

Dietary Supplement:
Essential fatty acids


Locations

Country Name City State
Germany Saarland University Hospital Homburg/Saar Saarland

Sponsors (1)

Lead Sponsor Collaborator
Saarland University

Country where clinical trial is conducted

Germany, 

Outcome

Type Measure Description Time frame Safety issue
Other Cued continous performance test - QB-version Motorhyper activity, concentration and impulsivity in adult ADHD patients 6 months
Primary Wender Reimherr Adult Attention Deficit Disorder Scale (WRAADDS) Psychopatholoy of adult ADHD 6 months
Secondary Short and long interval cortical inhibition (SICI and LICI) Motoric evoced potentials by transcranial magnetic stimulation (TMS) 6 months
See also
  Status Clinical Trial Phase
Recruiting NCT06000501 - Duration and Efficacy of Azstarys on Adult ADHD Symptoms and Executive Function in Early Evening Phase 4
Completed NCT03721588 - Clinical and Suicidal Features of Urban, Turkish Middle Age Depressive Patients With Comorbid ADHD
Completed NCT03324581 - The Safety and Efficacy of OPC-64005 in the Treatment of Adult Attention-deficit/Hyperactivity Disorder Phase 2
Recruiting NCT06221930 - Researching the Effectiveness of Attexis, a Digital Health Application for Adults With Attention Deficit Hyperactivity Disorder N/A
Completed NCT02160262 - Open-label Safety Study in Adults With ADHD Phase 3
Completed NCT02276209 - Dasotraline Adult ADHD Study Phase 3
Completed NCT01692782 - Adult Attention Deficit Hyperactivity Disorder Phase 2
Completed NCT00553319 - Study of Adderall-XR for the Treatment of Adult Attention Deficit Hyperactivity Disorder and Cocaine Dependence Phase 2/Phase 3